TRUH

TRUH employs a discretionary approach to construct a concentrated portfolio of US-listed healthcare companies. The approach targets large- and mid-cap market leaders with strong growth and solid operating performance. It focuses on key industries, including pharmaceuticals, biotechnology, life sciences tools and services, healthcare equipment and supplies, and healthcare providers and services. The strategy aims to reflect actual sector performance by providing full market-cap exposure, minimizing the underweighting of dominant firms. Conversely, the adviser actively manages the portfolio by increasing exposure to strong performers and reducing positions in companies with declining growth, weakening competitive positions, or deteriorating fundamentals. Holdings may include healthcare-sector ETFs, as well as derivatives such as total return swaps, which are generally capped at 20% of the portfolios notional value.